Molecular Imaging Probes to Inform Heterogeneity in Idiopathic Pulmonary Fibrosis

Abroad (travel likely)RecruitingPHASE1

Conditions

Idiopathic Pulmonary Fibrosis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The University of Alabama at Birmingham, Birmingham, Alabama, United States
Contact: Study coordinator (April Riddle, BSRT) · ariddle@uabmc.edu · 205-934-6504

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

NAL ER IPF Respiratory Function and Safety Study

Idiopathic Pulmonary Fibrosis

Abroad (travel likely)RecruitingPHASE1

Rochester, United States · Manchester, United Kingdom

FAPI PET for Lung Fibrosis

Interstitial Lung Disease · Idiopathic Interstitial Pneumonias · Drug-Induced Pneumonitis

Abroad (travel likely)RecruitingEARLY_PHASE1

Los Angeles, United States

Identification of Diagnostic and Prognostic Biomarkers in the Pathological Continuum of Bronco Chronic Obstructive Pulmonary Disease, Idiopathic Pulmonary Fibrosis and Pulmonary Neoplasia

COPD · Idiopathic Pulmonary Fibrosis (IPF) · Lung Cancer

Abroad (travel likely)Recruiting

Milan, Italy

Advanced Imaging to Assess the Effect of Immunosuppression on Progressive Fibrosis

Interstitial Lung Disease · Pulmonary Fibrosis

Abroad (travel likely)RecruitingPHASE2

Boston, United States